Sildenafil
سیلدنافیل
🚻 Genito Urinary System And Sex HormonesPDE5 inhibitor
Market / country: 🇺🇸 USA
Viagra (US)
🧮 Dose calculator
Erectile dysfunction · Regimen source: FDA Sildenafil · 2.1
- • 25–100 mg; at most once daily; 30 min to 4 h before. Over 65, hepatic impairment or CrCl <30: start 25 mg. With ritonavir max 25 mg per 48 h. FDA Sildenafil · 2FDA Sildenafil · 2.5FDA Sildenafil · 2.4
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ With any nitrate (nitroglycerin, isosorbide) or guanylate-cyclase stimulators (riociguat): severe hypotension. FDA Sildenafil · 4
Formulations
- 25 mg tablet — tablet 🇺🇸 USA FDA Sildenafil · 3
- 50 mg tablet — tablet 🇺🇸 USA FDA Sildenafil · 3
- 100 mg tablet — tablet 🇺🇸 USA FDA Sildenafil · 3
- 20 mg tablet (Revatio) — tablet 🇺🇸 USA FDA Revatio · 3
- 10 mg/mL oral suspension (Revatio, after reconstitution) — suspension 🇺🇸 USA FDA Revatio · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Sildenafil · 8.1
“Risk Summary Sildenafil is not indicated for use in females.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Sildenafil · 8.2
“Risk Summary Sildenafil is not indicated for use in females.”
- 👶 ChildrenUse with caution
Revatio label: approved for PAH in children 1–17 years; erectile-dysfunction use does not apply to children. FDA Revatio · 8.4
“The safety and efficacy of REVATIO have been established in pediatric patients 1 to 17 years old, for the treatment of PAH (WHO Group I) to improve exercise ability and, in patients too young to perform standard exercising testing, pulmonary hemodynamics thought to underlie improvements in exercise.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Sildenafil · 8.5
“Healthy elderly volunteers (65 years or over) had a reduced clearance of sildenafil resulting in approximately 84% and 107% higher plasma AUC values of sildenafil and its active N-desmethyl metabolite, respectively, compared to those seen in healthy young volunteers (18-45 years) [ see Clinical Pharmacology (12.3) ].”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA209302
- DailyMed (FDA label)FDA Sildenafil
- MedlinePlus (NIH)Sildenafil
- WHO ATC/DDDG04BE03
- Darooyab (Iran)Sildenafil
🇮🇷 Registered in Iran Darooyab · G-4223/Sildenafil
Dosage forms with Iranian generic codes, per Darooyab.
- 01780 · SILDENAFIL CITRATE 100MG TAB · قرص سیلدنافیل سیترات ۱۰۰ میلیگرم
- 02098 · SILDENAFIL CITRATE 25MG TAB · قرص سیلدنافیل سیترات ۲۵ میلیگرم
- 01781 · SILDENAFIL CITRATE 50MG TAB · قرص سیلدنافیل سیترات ۵۰ میلیگرم
- 51942 · SILDENAFIL 1 % 15 GRAM TOPICAL GEL · ژل موضعی سیلدنافیل ۱ درصد ۱۵ گرم
- 51120 · SILDENAFIL 1% 30 GRAM TOP GEL · ژل موضعی سیلدنافیل ۱ درصد ۳۰ گرم
- 52667 · SILDENAFIL 1 % 20 GRAM TOPICAL GEL · ژل موضعی سیلدنافیل ۱ درصد ۲۰ گرم
- 52512 · SILDENAFIL (AS CITRATE) TABLET, ORALLY DISINTEGRATING ORAL 50 mg · قرص بازشونده دهانی سیلدنافیل (معادل سیترات) بازشونده ۵۰ میلیگرم
- 52511 · SILDENAFIL (AS CITRATE) TABLET, ORALLY DISINTEGRATING ORAL 25 mg · قرص بازشونده دهانی سیلدنافیل (معادل سیترات) بازشونده ۲۵ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Sildenafil · 3FDA Revatio · 3FDA Sildenafil · 2.1FDA Sildenafil · 2FDA Sildenafil · 2.5FDA Sildenafil · 2.4FDA Revatio · 2.1FDA Revatio · 2.2FDA Sildenafil · 4FDA Sildenafil · 8.1FDA Sildenafil · 8.2FDA Revatio · 8.4FDA Sildenafil · 8.5FDA Sildenafil · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-4223/Sildenafil
- Clinical review⚠ Unverified